| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |